CooperVision, a world leader in myopia control and management for children, has announced new seven-year findings from its pivotal MiSight® 1 day contact lens clinical trial.

At the International Myopia Conference, CooperVision will offer new insights into the treatment efficacy of the fastest growing eyes fit with MiSight® 1 day contact lenses, derived from the world ...